Abstract
Objectives
We compared the outcome of thymectomy for myasthenia gravis (MG) in two healthcare systems. In Nottingham, UK, thymectomy is performed for thymic enlargement and considered in acetylcholine receptor (AchR) antibody positive patients. In Santiago, Cuba, thymectomy is considered in all generalised MG patients irrespective of their radiological findings or AchR antibodies.
Method
22 MG patients in Nottingham and 75 in Santiago who had a thymectomy were identified and their notes reviewed. We compared the median age, stage of disease, thymic histology and clinical outcome at two years post–thymectomy.
Results
The median ages for the Cuban and Nottingham patients were 25 and 35 years respectively. The median stage of disease was IIa by Osserman's classification in both. In Nottingham, 59% (13/22) showed an improvement compared with 88 % (66/75) in Santiago (p < 0.01). There were significantly more cases of thymoma in Nottingham whereas thymic hyperplasia and atrophy were a more frequent finding in Cuban patients. The majority of cases who improved post–thymectomy had thymic hyperplasia on histology in both Nottingham (46%) and Cuban (61%) patients.
Conclusion
Selecting MG patients based on thymic enlargement alone or AchR antibody positivity may be inadequate and thymectomy should perhaps be considered in all patients with generalised myasthenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Batra P, Herrmann C Jr, Mulder D (1987) Mediastinal imaging in myasthenia gravis: correlation of chest radiography, CT, MR, and surgical findings. AJR Am J Roentgenol 148:515–519
Blalock A, Manson MF, Morgan HJ, Riven SS (1939) Myasthenia gravis and tumours of the thymic region. Ann Surg 110:544–561
Gronseth GS, Barohn RJ (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence–based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:7–15
Higuchi T, Taki J, Kinuya S, Yamada M, Kawasuji M, Matsui O, Nonomura A, Bunko H, Tonami N (2001) Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy. Radiology 221:201–206
Jaretzki A 3rd, Penn AS, Younger DS, Wolff M, Olarte MR, Lovelace RE, Rowland LP (1988) "Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg 95:747–757
Lacquer L, Weigert C (1901) Beiträge zur Lehre von der Erb'schen Krankheit ueber die Erbsche Krankheit (myasthenia gravis). Neurol Zentralblatt 20:594–601
Lanska DJ (1990) Indications for thymectomy in myasthenia gravis. Neurology 40:1828–1829
Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caraco C, Bianco RA, Muto P, Salvatore M (1998) In vivo detection of malignant thymic masses by indium–111–DTPA–D–Phe1– octreotide scintigraphy. J Nucl Med 39:634–639
Newsom–Davis J (1992) Diseases of the neuromuscular junction. Philadelphia:WB Saunders
Pirronti T, Rinaldi P, Batocchi AP, Evoli A, Di Schino C, Marano P (2002) Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol 43:380–384
Remes–Troche JM, Tellez–Zenteno JF, Estanol B, Garduno–Espinoza J, Garcia– Ramos G (2002) Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res 33:545–551
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shahrizaila, N., Pacheco, O.A., Vidal, D.G. et al. Thymectomy in myasthenia gravis: Comparison of outcome in Santiago, Cuba and Nottingham, UK. J Neurol 252, 1262–1266 (2005). https://doi.org/10.1007/s00415-005-0015-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0015-9